Assembly Biosciences (ASMB) Interest Expenses (2010 - 2025)
Assembly Biosciences (ASMB) posted quarterly Interest Expenses of $17.2 million for Q4 2025, down 91.86% year-over-year from $211.6 million in Q4 2024, and down 91.86% quarter-over-quarter from $211.6 million in Q4 2024.
Assembly Biosciences (ASMB) Interest Expenses (2010 - 2025) Analysis & Trends
Assembly Biosciences' Interest Expenses history runs 14 years deep, the most recent figure standing at $17.2 million for Q4 2025.
- In Q4 2025, Interest Expenses fell 91.86% year-over-year to $17.2 million; the TTM figure through Dec 2025 stood at $17.2 million (down 91.86% YoY), while the FY2025 annual figure was $17.2 million, down 91.86% from the prior year.
- Interest Expenses for Q4 2025 stood at $17.2 million, down from $211.6 million in the prior quarter.
- The five-year high for Interest Expenses was $211.6 million in Q4 2024, with the low at $1000.0 in Q3 2022.
- The 5-year median for Interest Expenses is $1.0 million (2021), against an average of $22.0 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses plunged 99.99% in 2022, then soared 1113657.89% in 2024.
- Assembly Biosciences' Interest Expenses stood at $930000.0 in 2021, then jumped by 47.53% to $1.4 million in 2022, then tumbled by 98.62% to $19000.0 in 2023, then jumped by 1113657.89% to $211.6 million in 2024, then slumped by 91.86% to $17.2 million in 2025.
- Business Quant data shows ASMB's Interest Expenses at $17.2 million in Q4 2025, $211.6 million in Q4 2024, and $19000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.22 Mn |
| Dec 31, 2025 | 17.22 Mn |
| Dec 31, 2024 | 211.61 Mn |
| Dec 31, 2024 | 211.61 Mn |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 1.37 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 243,000.00 |
| Jun 30, 2022 | 243,000.00 |
| Mar 31, 2022 | 162,000.00 |
| Mar 31, 2022 | 162,000.00 |
| Dec 31, 2021 | 930,000.00 |
| Dec 31, 2021 | 930,000.00 |
| Sep 30, 2021 | 8.07 Mn |
| Sep 30, 2021 | 8.07 Mn |
| Jun 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.02 Mn |